You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2010 or most recent year available
Part (iv) Outpatient clients by secondary drug and primary drug
| Secondary drug | ||
|---|---|---|
| Opioids | 878 | 32 |
| Cocaine | 771 | 193 |
| Cannabis | 2857 | 277 |
| Alcohol | 1894 | 224 |
| Stimulants (other than cocaine) | 627 | 102 |
| Hypnotics and sedatives | 754 | 41 |
| Hallucinogens | 162 | 31 |
| Volatile | 45 | 0 |
| Other substances | 136 | 14 |
| Total number of citations | 8124 | 914 |
Notes
Clients may report one primary drug, but more than one secondary drug
Countries providing data are:
BE, BG, CZ, DK, EE, IE, GR, ES, FR, IT, CY , LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR.
The number of treatment clients in each country is listed in Table TDI-7.
See also 'General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — Table TDI by centre type.